The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of pectasol-c modified citrus pectin (P-MCP) treatment (tx) on PSA dynamics in non-metastatic biochemically relapsed prostate cancer (BRPC) patients (pts): Results of a prospective phase II study.
 
Daniel Keizman
Honoraria - Bayer; Janssen Oncology; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Bayer; Janssen Oncology; Pfizer; Sanofi
 
Moshe A. Frenkel
No Relationships to Disclose
 
Avivit Peer
No Relationships to Disclose
 
Eli Rosenbaum
No Relationships to Disclose
 
David Margel
No Relationships to Disclose
 
David Leonid Sarid
No Relationships to Disclose
 
Victoria Neiman
No Relationships to Disclose
 
Maya Gottfried
No Relationships to Disclose
 
Natalie Maimon
No Relationships to Disclose
 
Ilan Leibovitch
No Relationships to Disclose
 
Hadas Dresler
No Relationships to Disclose
 
Isaac Eliaz
Employment - ecoNugenics
Leadership - ecoNugenics
Stock and Other Ownership Interests - ecoNugenics
Speakers' Bureau - ecoNugenics
Travel, Accommodations, Expenses - ecoNugenics